About N Focus Neuro
N Focus Neuro is a Healthcare company based in Palo Alto (United States) founded in 2007, and was acquired by Covidien in February 2013. Endovascular neurosurgery solutions are developed for intracranial aneurysm treatment. N Focus Neuro has raised $16.7 million across 3 funding rounds from investors including Covidien and VentureHealth. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is Nfocus Neuromedical, Inc. Its competitors include MicroVention, CoAxia and Concentric Medical; 2 of its 3 listed competitors have raised funding.
Company details
N Focus Neuro was founded in 2007 in Palo Alto, United States, where endovascular neurosurgery solutions are developed for treating intracranial aneurysms. Operations are centered in the medical device sector, with emphasis on neurosurgical interventions. Services include specialized devices for endovascular procedures, supporting clinical applications in aneurysm management. The companys activities are based in the United States, accessible via nfocusneuro.com.
- Headquarters Palo Alto, United States
- Stage Acquired
- SectorsHealthcare
- Website nfocusneuro.com
- Acquired by Covidien (Feb 2013)
- Legal Name Nfocus Neuromedical, Inc
Funding Insights of N Focus Neuro
N Focus Neuro has successfully raised a total of $16.7M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $1.49 million completed in June 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16.7M
- Total Rounds 3
- Last Round Series B — $1.49M
- First Round $7.67M
(Jul 2009)
- Investors Count 1
All 3 funding rounds of N Focus Neuro with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2014 | $1.49M | Series B | – | VentureHealth | – |
| Apr 2011 | $7.54M | Series B | – | – | – |
| Jul 2009 | $7.67M | Series B | – | – | – |
2 investors in total: 2 institutional.
Investors in N Focus Neuro
N Focus Neuro has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Covidien and VentureHealth.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare sector investments are managed by VentureHealth venture capital fund. | venturehealth.com | San Jose, United States | ||
Medical devices for minimally invasive therapies are provided globally. | 2007 | covidien.com | Dublin, Ireland |
Investor details for N Focus Neuro
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of N Focus Neuro
4 dated milestones of N Focus Neuro across 7 years, from founding to its latest funding, stage changes and deals.
- Founded N Focus Neuro is founded.
- Funding First funding round of $7.7M.
- Exit Acquired by Covidien.
- Funding Latest funding round, Series B, of $1.5M.
Competitors of N Focus Neuro
N Focus Neuro has 3 listed competitors in our database, 2 of them funded. They include MicroVention, CoAxia and Concentric Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| microvention.com | 1997 | Tustin, United States | Neuroendovascular technologies for cerebral and peripheral vascular diseases are developed. | |||
| coaxia.com | 1999 | Maple Grove, United States | $72.6M | Catheter-based treatment for cerebral ischemia | ||
| concentric-medical.com | 1999 | Mountain View, United States | $39.92M | Endovascular devices are manufactured for removing clots in ischemic stroke. |
Detailed competitors of N Focus Neuro
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Neurology
3 companies that operate in the same segment as N Focus Neuro (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about N Focus Neuro
Complete news archive for N Focus Neuro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about N Focus Neuro
N Focus Neuro was founded in 2007 and raised its 1st funding round 2 years after it was founded.
N Focus Neuro is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
N Focus Neuro is a funded company, having raised a total of $16.7M across 3 funding rounds to date. The company's 1st funding round was a Series B of $7.67M, raised on Jul 2009.
N Focus Neuro was founded in 2007 in Palo Alto, United States, where endovascular neurosurgery solutions are developed for treating intracranial aneurysms. Operations are centered in the medical device sector, with emphasis on neurosurgical interventions. Services include specialized devices for endovascular procedures, supporting clinical applications in aneurysm management. The companys activities are based in the United States, accessible via nfocusneuro.com.
N Focus Neuro's top competitors include MicroVention, Concentric Medical and CoAxia.
N Focus Neuro has 2 investors. Key investors include Covidien, and VentureHealth.
N Focus Neuro operates through Nfocus Neuromedical, Inc.
Yes. N Focus Neuro was acquired by Covidien in February 2013.